| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00544582 |
| P953 | full work available at URL | http://link.springer.com/content/pdf/10.1007/BF00544582.pdf |
| http://link.springer.com/article/10.1007/BF00544582/fulltext.html | ||
| http://link.springer.com/content/pdf/10.1007/BF00544582 | ||
| P698 | PubMed publication ID | 7238561 |
| P2093 | author name string | J. Feely | |
| I. H. Stevenson | |||
| J. Crooks | |||
| P2860 | cites work | British Journal of Pharmacology | Q919631 |
| The Use of Propranolol in the Surgical Treatment of Thyrotoxic Patients | Q54205678 | ||
| The kinetics of propranolol in hypothyroidism [proceedings]. | Q64891547 | ||
| Propranolol kinetics in hyperthyroidism [proceedings] | Q66970986 | ||
| The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat | Q67251918 | ||
| The predictable relationship between plasma levels and dose during chronic propranolol therapy | Q67403369 | ||
| The effect of age and hyperthyroidism on plasma propranolol steady state concentration [proceedings] | Q67427180 | ||
| Variable plasma propranolol levels in thyrotoxicosis | Q67465302 | ||
| GLC determination of propranolol, other beta-blocking drugs, and metabolites in biological fluids and tissues | Q70057091 | ||
| Propranolol dosage in thyrotoxicosis | Q71302905 | ||
| Studies of the effect of thyroid dysfunction on the elimination of beta-adrenoreceptor blocking drugs | Q34515525 | ||
| Plasma protein binding of propranolol and isoprenaline in hyperthyroidism and hypothyroidism | Q34516750 | ||
| The effect of ageing on the hepatic clearance of propranolol | Q34517399 | ||
| Proceedings: Changes in drug metabolizing ability in thyroid disease | Q35600582 | ||
| The use of kanamycin in equilibrium dialysis at 37° | Q39068733 | ||
| Preoperative treatment of thyrotoxicosis with a beta-adrenergic blocking agent | Q39079624 | ||
| Clinical Pharmacokinetics of Propranolol | Q39798751 | ||
| Drug metabolism in thyroid disease | Q40640582 | ||
| Effects of age and cigarette smoking on propranolol disposition | Q41617556 | ||
| Plasma protein binding of propranolol in disease states [proceedings] | Q42255511 | ||
| A simple, small-volume ultrafiltration apparatus applicable to protein binding studies [proceedings] | Q43457136 | ||
| Propranolol serum levels during twenty-four hours | Q44696610 | ||
| Propranolol does not prevent thyroid storm | Q44903156 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 329-333 | |
| P577 | publication date | 1981-01-01 | |
| P1433 | published in | European Journal of Clinical Pharmacology | Q1376707 |
| P1476 | title | Plasma propranolol steady state concentrations in thyroid disorders | |
| P478 | volume | 19 |
| Q40089881 | Clinical Pharmacokinetics of ??-Adrenoceptor Blocking Drugs in Thyroid Disease |
| Q39693651 | Clinical pharmacokinetics and endocrine disorders. Therapeutic implications |
| Q37950599 | Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II). |
| Q68535415 | Pharmacokinetics of theophylline in hyperthyroid and hypothyroid patients with chronic obstructive pulmonary disease |
Search more.